Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 ENFERMEDAD GRUPO REGISTRY PROYECTOS ENTRAR
 
 
  
Wet Biomarkers -
--->Novedades
[-]El proyecto
--->Sponsor
--->[+]Comité Ejecutivo
--->[+]Writing Committee Strategic ...
--->[-]Comité Científico y Bioético
--->Becanovic
--->Busse
--->Frontali
--->Giorgini
--->Holmans
--->Mariotti
--->Norremolle
--->Reetz
--->Rickards
--->Saft
--->van Duijn
--->Valenza
--->Verellen
--->Documentos públicos
--->Coordinador central
--->Coordinadores locales
--->Fellowship Programme
--->[-]Constitución
--->Artículo 1
--->Artículo 2
--->Artículo 3
--->Artículo 4
--->Artículo 5
--->Artículo 6
--->Artículo 7
--->Artículo 8
--->Artículo 9
--->Artículo 10
--->Artículo 11
--->Artículo 12
--->Documentos
--->[-]Elecciones
--->[+]Miembros
[-]Centros
--->[+]Austria
--->[+]Bélgica
--->[+]República Checa
--->[+]Dinamarca
--->[+]Finlandia
--->[+]Francia
--->[-]Alemania
--->Coordinador
--->Asociaciones de EH
--->Standard of Care
--->Aachen
--->Berlin
--->Bochum
--->Bonn
--->Dresden
--->Dinslaken
--->Düsseldorf
--->Erlangen
--->Freiburg
--->Hamburg
--->Hannover
--->HH-Heiligenhafen
--->Itzehoe
--->Marburg
--->[+]Lübeck
--->Marburg-KPP
--->Mainz
--->München
--->München-LMU
--->Münster
--->Rostock
--->Taufkirchen
--->Ulm
--->[+]Würzburg
--->[+]Ireland
--->[+]Italia
--->[+]Países Bajos
--->[+]Noruega
--->[+]Polonia
--->[+]Portugal
--->[+]Rusia
--->[+]España
--->[+]Suecia
--->[+]Suiza
--->[-]Reino Unido
--->Coordinación
--->Asociaciones de Huntingto...
--->Links
--->[+]UKHDN
--->Standard of Care
--->Aberdeen
--->[+]Ayr
--->Belfast
--->Birmingham
--->[+]Blandford Forum
--->Bristol
--->Cambridge
--->Cardiff
--->Dundee
--->Edinburgh
--->Exeter
--->Fife
--->Forth Valley
--->Glasgow
--->Gloucester
--->Hull
--->Inverness
--->Launceston
--->Leeds
--->Leicester
--->Liverpool
--->Londres - Guy's Hospital
--->Londres - Hammersmith
--->Londres - NHNN
--->Londres - Royal Hospital
--->Londres St. George´s
--->Manchester
--->Newcastle-Upon-Tyne
--->[+]Northampton
--->Nottingham
--->Oxford
--->[+]Plymouth
--->Poole
--->Preston
--->Reading
--->[+]Sheffield
--->Southampton
--->Stoke-on-Trent
--->Swindon
--->Wrexham
--->[+]Fuera de Europa
[-]Grupos de trabajo
--->[-]EH avanzada
--->Acontecimientos
--->[+]Reuniones
--->[-]Fenotipo conductual
--->Dates
--->[+]Meetings
--->[+]Psycho appr. & interv. Sub...
--->[+]Modificadores Biológicos
--->[+]Biomarcadores
--->[+]Banco de tejidos y cerebros...
--->[-]Fenotipo cognitivo
--->[+]Acontecimientos
--->[+]Reuniones
--->[-]Modificadores ambientales
--->[+]Acontecimientos
--->[-]Reuniones
--->Reunión de 2009
--->[-]Evaluación Funcional
--->Acontecimientos
--->[+]Reuniones
--->[+]Test y Consejo genético
--->[+]Genes Modificadores
--->[+]Economia de Salud
--->[+]Pruebas de imagen
--->[-]Huntington Juvenil
--->Acontecimientos
--->[-]Fenotipo motor
--->[-]Acontecimientos
--->[+]Reuniones
--->[+]Tratamiento Neuroprotector...
--->[-]Fisioterapia
--->Acontecimientos
--->[+]Reuniones
--->[-]Calidad de vida
--->[+]Acontecimientos
--->[+]Reuniones
--->[+]Cuidados del paciente
--->[+]Tratamiento quirúrgico
--->[+]Tratamiento Sintomático
--->[+]Jóvenes
[-]Eventos
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[+]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[-]Travel and Location
--->Congress & Meeting Ven...
--->Travel Information
--->Accommodation
--->[+]About Prague
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[-]EHDN 2008
--->Programa
--->Otras reuniones
--->Programa de la AHE
--->Programa social
--->Programa infantil
--->Fechas a recordar
--->Voting
--->Reembolso
--->[+]Inscripción
--->[+]Submisión de abstracts
--->Evaluation & Feedback
--->[+]Viaje y alojamiento
--->[+]Lisboa
--->[+]Documentos
--->Comités
--->Contacto
--->[-]EHDN 2007
--->Programa
--->Reuniones
--->Bienvenido
--->[+]Sobre Dresden
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Programa
--->Cena oficial
--->Inscripción
--->Grupos de Trabajo
--->Localización
--->Manchester
--->Valoración y Feedback
--->[+]EHDN 2004
[-]Comunicación
--->¿Cómo contactar?
--->Forums
--->Listas de correos
--->Publicación
--->Ofertas de trabajo
fechadescripcióntamañoautor documento 
03.08.26Selisistat: potential pharmacodynamic readouts based on transcriptomics32 kBanonymousapplication/mswordf04-potential-pharmacodynamic-readouts 
03.08.26Mutant Huntingtin fragmentation in immune cells tracks Huntington’s Disease progression32 kBanonymousapplication/mswordf05-mutant-huntingtin-fragmentation 
03.08.26Whole blood SAGE digital gene expression profiling from Huntington's disease patients32 kBanonymousapplication/mswordf03-blood-sage-digital-gene-expression 
03.08.26Selisistat: Soluble htt protein levels as a potential pharmacodynamic readout32 kBanonymousapplication/mswordf02-soluble-htt-protein-levels 
03.08.26Establishment of novel assays for quantification of full-length wild-type and mutant Huntingtin by using the AlphaLISA technology32 kBanonymousapplication/mswordf01-establishment-novel-assays 
03.08.26A critical evaluation of inflammatory markers in Huntington’s Disease plasma32 kBanonymousapplication/mswordf06-critical-evaluation-inflammatory-m... 
03.08.26Cross-sectional and longitudinal associations between CRP and neuropsychiatric symptoms in HD32 kBanonymousapplication/mswordf07-crp-neuropsychiatric-symptoms 
03.08.26Abnormal regulation of macrophage-derived transforming growth factor – β 1 (TGF-β1) production in Huntington Disease32 kBanonymousapplication/mswordf12-abnormal-regulation-of-macrophage 
03.08.268OHdG is not a biomarker for Huntington’s Disease; lessons for future biomarker studies32 kBanonymousapplication/mswordf14-8ohdg 
03.08.26Progredient deterioration of hepatic mitochondrial function in Huntington's Disease – measured by using the 13C-methionin breath test32 kBanonymousapplication/mswordf11-progredient-deterioration-hepatic-... 
03.08.26The study on molecular changes related to energy metabolism in Huntington’s disease subjects - looking for biomarkers32 kBanonymousapplication/mswordf09-molecular-changes-related-to-energ... 
03.08.26The autoimmune profile of Huntington`s Disease patients - a pilot study32 kBanonymousapplication/mswordf08-autoimmune-profile 
03.08.26A new biomarker in Huntington's disease32 kBanonymousapplication/mswordf15-new-biomarker 

Esta carpeta contiene 13 documentos.
about us | privacy statement | disclaimer | terms of use